Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Delayed
Canadian Securities Exchange
20:26:38 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.6200 CAD | 0.00% |
|
-1.59% | -11.43% |
| 08-21 | Grown Rogue Shares up 13%, Says Forming Subsidiary to Acquire Cannabis Assets in New York | MT |
| 08-05 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| Market Cap | 112M 96.33M 90.4M 82.71M 154M 10.58B 156M 1.07B 416M 5.41B 420M 411M 17.42B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 127M 109M 103M 94.01M 175M 12.03B 177M 1.22B 473M 6.15B 478M 467M 19.8B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.86% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript : Grown Rogue International Inc.
| 1 week | -1.59% | ||
| 1 month | +6.90% | ||
| 3 months | +5.08% | ||
| 6 months | +42.53% | ||
| Current year | -11.43% |
| 1 week | 0.59 |  | 0.65 |
| 1 month | 0.56 | | 0.69 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.27 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 14/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.59% | +5.08% | +110.17% | 112M | |
| +0.34% | +1.03% | -14.94% | -6.95% | 13.43B | |
| -0.71% | -2.49% | -33.30% | -56.88% | 4.87B | |
| +0.32% | -2.52% | -7.81% | -5.22% | 4.5B | |
| -0.19% | -2.00% | -6.26% | -31.77% | 3.92B | |
| -0.72% | -1.97% | -23.29% | +1.39% | 3.55B | |
| -2.27% | -0.04% | -2.38% | -4.50% | 3.43B | |
| -0.88% | -0.95% | -10.63% | +4.57% | 3.25B | |
| -1.46% | -4.32% | -23.44% | -14.97% | 2.33B | |
| -0.89% | -1.63% | -27.68% | -17.05% | 1.7B | |
| Average | -0.65% | -2.01% | -14.46% | -2.12% | 4.11B | |
| Weighted average by Cap. | -0.40% | -1.02% | -15.79% | -13.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.25M 21.81M 19.96M 37.25M 2.55B 37.55M 258M 100M 1.31B 101M 99.24M 4.2B | 32.43M 27.9M 26.18M 23.96M 44.71M 3.07B 45.07M 310M 121M 1.57B 122M 119M 5.05B |
| Net income | -11.3M -9.73M -9.13M -8.35M -15.59M -1.07B -15.71M -108M -42.05M -546M -42.45M -41.52M -1.76B | 1.73M 1.49M 1.4M 1.28M 2.39M 164M 2.4M 16.52M 6.43M 83.56M 6.5M 6.35M 269M |
| Net Debt | 3.7M 3.19M 2.99M 2.74M 5.11M 350M 5.15M 35.38M 13.78M 179M 13.91M 13.61M 576M | 15.3M 13.16M 12.35M 11.3M 21.09M 1.45B 21.26M 146M 56.91M 739M 57.45M 56.2M 2.38B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | CA$0.6200 | 0.00% | 4,000 |
| 02/09/26 | CA$0.6200 | 0.00% | 28,500 |
| 01/09/26 | CA$0.6200 | 0.00% | 7,000 |
| 31/08/26 | CA$0.6200 | -1.59% | 10,500 |
| 28/08/26 | CA$0.6300 | 0.00% | 18,562 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
